Auto-antibodies against type i ifns in > 10% of critically ill covid-19 patients: a prospective multicentre study

HIGHLIGHTS

• who: Romain Arrestier from the Assistance Paris, Cru00e9teil, Paris, France have published the research work: Auto-antibodies against type I IFNs inu2009>u200910% of critically ill COVID-19 patients: a prospective multicentre study, in the Journal: (JOURNAL)
• what: The authors conducted a multicenter cohort of COVID-19 patients requiring ICU admission and aimed to: compare the severity of patients at admission and_(2) compare the mortality of patients with versus without auto-Abs neutralizing type I INFs.
• how: The authors conducted a prospective multicentre cohort study including patients admitted in 11 intensive care . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.